Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A price you saw in an ad may not apply once the medical review narrows your options to what is clinically appropriate for you
The UK Summary of Product Characteristics (SmPC) for semaglutide, liraglutide and tirzepatide specifically states they should not be used during breast-feeding due to lack of human data
The 2.5 mg dose is delivered as a single-use pen containing exactly 2.5 mg in 0.5 mL of solution
.jpg)
Managing diabetes, heart disease, obesity, or depression is not an emergency
US$ 29.46
US$ 23.73
US$ 22.40
